This list is an analysis based on recent market events. It's not an investment recommendation.
About
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
The current price of GRAL.MX is M$825 MXN — it has increased by +0% in the past 24 hours. Watch GRAIL stock price performance more closely on the chart.
What is GRAIL stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange GRAIL stocks are traded under the ticker GRAL.MX.
What is GRAIL market cap?▼
Today GRAIL has the market capitalization of 32.16B
When is the next GRAIL earnings date?▼
GRAIL is going to release the next earnings report on May 05, 2026.
What were GRAIL earnings last quarter?▼
GRAL.MX earnings for the last quarter are -42.07 MXN per share, whereas the estimation was -46.55 MXN resulting in a +9.63% surprise. The estimated earnings for the next quarter are N/A MXN per share.
What is GRAIL revenue for the last year?▼
GRAIL revenue for the last year amounts to 1.98B MXN.
What is GRAIL net income for the last year?▼
GRAL.MX net income for the last year is -5.94B MXN.